Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Roche”

Observational Study of Vismodegib (Erivedge) in Patients Treated in ArgentinaCompleted
NCT02438644N/AUpdated Feb 26, 2018
Sponsor: Hoffmann-La Roche
Basal Cell Carcinoma
Antimullerian Hormone in EndometriomasCompleted
NCT02669628N/AUpdated Feb 23, 2018
Sponsor: Hospital Universitari de Bellvitge
Endometriomas
Spain
Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT)Completed
NCT00462995Phase 2Updated Feb 23, 2018
Sponsor: University Health Network, Toronto
Non Small Cell Lung Cancer
Canada
A Study Examining Maintenance Bevacizumab (Avastin®) Monotherapy in Participants With Advanced Lung AdenocarcinomaCompleted
NCT02093000N/AUpdated Feb 23, 2018
Sponsor: Hoffmann-La Roche
Lung Adenocarcinoma
Hungary
Evaluation of Dexamethasone Added to the Usual Infiltration With Bupivacaine in Inguinal Hernia Repair MeshCompleted
NCT03007927Phase 4Updated Feb 22, 2018
Sponsor: SEBASTIAN ROCHE
Pain, Postoperative
Argentina
A Study of Hypoxia-inducible Factor 1a (HIF1A) Messenger Ribonucleic Acid (mRNA) Antagonist (RO7070179), to Demonstrate Proof-of-mechanism in Adult Participants With Hepatocellular Carcinoma (HCC)Completed
NCT02564614Phase 1Updated Feb 15, 2018
Sponsor: Hoffmann-La Roche
Carcinoma, Hepatocellular
United States
A Study of The Impact of Severe Hepatic Impairment on the Pharmacokinetics and Safety of Vemurafenib in BRAF V600 Mutation-Positive Cancer ParticipantsCompleted
NCT01767623Phase 1Updated Feb 13, 2018
Sponsor: Hoffmann-La Roche
Neoplasms
United States, Australia, Greece, Israel, Russia +2 more
An Extension Study to WA19977 in Patients With Active Polyarticular-Course Juvenile Idiopathic ArthritisTerminated
NCT01575769Phase 3Updated Feb 9, 2018
Sponsor: Hoffmann-La Roche
Juvenile Idiopathic Arthritis
Poland, Russia
A Long-Term Extension Study to WA19926 (NCT01007435) of Tocilizumab in Participants With Early, Moderate to Severe Rheumatoid ArthritisTerminated
NCT01665430Phase 3Updated Feb 8, 2018
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Poland
Long Term Extension Study is Designed to Monitor Long-Term Efficacy and Safety of Miravirsen Sodium in Combination With Telaprevir and Ribavirin in Subjects With Chronic Hepatitis C Virus Genotype 1 InfectionCompleted
NCT02452814N/AUpdated Feb 6, 2018
Sponsor: Hoffmann-La Roche
HCV
United States, Puerto Rico
A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent GlioblastomaCompleted
NCT01632228Phase 2Updated Feb 5, 2018
Sponsor: Hoffmann-La Roche
Glioblastoma
United States, Canada, France, Germany, Italy +3 more
A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous ChemotherapyCompleted
NCT01364012Phase 3Updated Feb 5, 2018
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer
China
Psychosocial Issues in Insulin Pump Therapy in Children With Type 1 Diabetes Mellitus (DM)Completed
NCT01338922NAUpdated Feb 5, 2018
Sponsor: University Hospital Schleswig-Holstein
Diabetes Mellitus, Insulin-Dependent
Germany
HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta HepatitisCompleted
NCT00932971Phase 2Updated Jan 29, 2018
Sponsor: HepNet Study House, German Liverfoundation
Hepatitis D
Germany, Greece, Romania
A Study of Subcutaneous RoActemra/Actemra (Tocilizumab) as Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Patients With Active Rheumatoid ArthritisCompleted
NCT01995201Phase 3Updated Jan 26, 2018
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Ireland, Portugal, Spain
A Real World Study to Evaluate Effectiveness of Avastin (Bevacizumab) for First Line Treatment of Patients With Metastatic Colorectal Cancer and Known KRAS StatusCompleted
NCT02831842N/AUpdated Jan 26, 2018
Sponsor: Hoffmann-La Roche
Colorectal Cancer
A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With HerceptinCompleted
NCT01152606N/AUpdated Jan 25, 2018
Sponsor: Hoffmann-La Roche
Breast Cancer
Austria, Belgium, Germany, Hungary, Italy +4 more
A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRIGGER)Completed
NCT01378962Phase 2Updated Jan 23, 2018
Sponsor: Hoffmann-La Roche
Non-Squamous Non-Small Cell Lung Cancer
Italy
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast CancerCompleted
NCT00950300Phase 3Updated Jan 23, 2018
Sponsor: Hoffmann-La Roche
Breast Cancer
Argentina, Brazil, Canada, Colombia, Czechia +21 more
A Study of Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3aCompleted
NCT01724021Phase 3Updated Jan 23, 2018
Sponsor: Hoffmann-La Roche
Diffuse Large B-Cell Lymphoma, Non-Hodgkin's Lymphoma
Argentina, Australia, Austria, Brazil, Canada +27 more
Ribavirin, Its Dosing RegimeCompleted
NCT00484328Phase 4Updated Jan 9, 2018
Sponsor: Maastricht University Medical Center
Hepatitis C
Netherlands
A Two Part Study of RO6870810. Dose-Escalation Study in Participants With Advanced Solid Tumors and Expansion Study in Participants With Selected MalignanciesCompleted
NCT01987362Phase 1Updated Jan 5, 2018
Sponsor: Hoffmann-La Roche
Solid Tumors, Advanced Solid Tumors
United States
A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.Completed
NCT00048048Phase 2Updated Jan 2, 2018
Sponsor: Hoffmann-La Roche
Anemia
United States, Canada, Mexico, Poland, United Kingdom
Multicenter, Post-marketing, Non-interventional, Observational Study in RA Patients Treated With RoActemra/Actemra (Tocilizumab)Completed
NCT02101307N/AUpdated Dec 29, 2017
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
China
An Observational Study of First-Line Maintenance Rituximab (MabThera/Rituxan) in Participants With Follicular Non-Hodgkin's LymphomaCompleted
NCT01684865N/AUpdated Dec 29, 2017
Sponsor: Hoffmann-La Roche
Non-Hodgkin's Lymphoma
North Macedonia

Previous page Next page